Tuesday September 25, 2018

Drinking hot tea may be less likely to develop glaucoma

0
//
72
Drinking hot tea may be less likely to develop glaucoma
FILE - A woman walks in a yard where tea leaves are dried at a tea company in Dening, Fujian Province, China, April 2, 2016. U.S. researchers say people who drink hot tea daily may be less likely than others to develop glaucoma symptoms. VOA
Republish
Reprint

January 1, 2018: People who drink hot tea daily may be less likely than others to develop glaucoma symptoms, U.S. researchers say.

Compared to coffee, soft drink and iced tea drinkers, study participants who consumed a cup or more of hot caffeinated tea daily had 74 percent lower odds of having glaucoma, the study authors report in the British Journal of Ophthalmology.

“Glaucoma can lead to blindness, and it would be great if it could be prevented because there is no cure,” said lead author Dr. Anne Coleman of the University of California, Los Angeles.

“The best way to prevent it is to get your eyes checked,” Coleman told Reuters Health in a telephone interview. “But we are also interested in lifestyle habits and what we can do to make a difference.”

Glaucoma is the second leading cause of blindness worldwide, according to the World Health Organization, affecting an estimated 58 million people. That includes more than three million Americans, only half of whom are aware they have the disease, according to the Glaucoma Research Foundation.
Coffee, or caffeine in general have previously been linked to increased glaucoma risk, although recent studies don’t agree, Coleman and her colleagues write.

To evaluate the relationship between specific caffeinated drinks and glaucoma, Coleman and colleagues analyzed data on a sample of more than 10,000 people in the U.S. who were representative of the entire population.

Participants in the National Health and Nutrition Examination Survey during 2005-2006 answered questions about their diets and lifestyles, had medical exams and blood tests and also underwent eye examinations.

About 1,700 participants were over age 40, had no other known eye diseases and had full eye examination results from the survey. In this group, Coleman’s team found that just over 5 percent, 82 people, had glaucoma.

Almost half of participants reported drinking coffee often, but less than 10 percent drank hot tea daily. The research team found no associations between coffee, iced tea, decaffeinated tea or soft drink consumption and the likelihood of having glaucoma.

“Tea drinkers should keep drinking and don’t need to stop because of a fear of glaucoma,” Coleman said. “This makes sense, but we’ll see if it holds up in future studies.”

Future studies should look at the habits, activities and nutrition that affect lifestyle and glaucoma risks, said Idan Hecht of Tel-Aviv University in Israel, who wasn’t involved in the research.

“In the past few years, there has been a tremendous increase in interest, and subsequently research, into the ways lifestyle changes can influence diseases,” Hecht told Reuters Health by email.

Recent research indicates that vitamins C, E and zinc can help vision. Other studies indicate that antioxidants in tea could have similar effects, he noted.

“Patients can and should be involved and take an active role in the management of their ailments,” Hecht said. “Exercising, eating healthy and trying novel ways to improve your health is something you should definitely explore and bring up with your physician.”

Environmental factors could play a role in glaucoma risk as well, said Dr. Ahmad Aref at the University of Illinois at Chicago.

“As our population grows older, we need to think about the other factors that could help, particularly when it comes to the health benefits of physical activity,” he told Reuters Health by phone.

Overall, both medical and non-medical approaches are key to treating the disease in the future, Aref added.

“It’s a tough disease because we don’t have a way to bring vision back once it’s lost,” he said. “All we can do is prevent it from getting worse, and we want to help patients do that.” (VOA)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Gene Therapy Wins Big at Portugal’s Champalimaud Foundation

The foundation, which focuses on neuroscience and oncology research at its Lisbon base, was set up at the bequest of Portugal's late industrialist Antonio Champalimaud.

0
Gene Theory
ean Bennett, Albert Maguire, Robin Ali, James Bainbridge, Samuel Jacobson, T. Michael Redmond and Portugal's President Marcelo Rebelo de Sousa attend the 2018 Antonio Champalimaud Vision Awards ceremony at Champalimaud Foundation in Lisbon, Portugal, VOA

Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won a 1 million euro ($1.15 million) prize Tuesday, Portugal’s Champalimaud Foundation said.

Established in 2006, the annual award for work related to vision is one of the world’s largest science prizes, more than the latest 9 million Swedish crown ($987,000) Nobel Prize in Physiology or Medicine.

“This is the first, and still only, example of successful gene therapy in humans that corrects an inherited genetic defect and is therefore a milestone in medical therapeutics,” said Alfred Sommer, Dean Emeritus of the Johns Hopkins Bloomberg School of Public Health and chairman of the award jury.

Gene
Colour sensitivity can also led to Retinal Diseases/Blindness. Pixabay

One of those honored, Michael Redmond of the National Eye Institute in Maryland, had traced the cause of the disease, Leber congenital amaurosis (LCA), to a mutated gene.

Three cooperating research teams later managed to replace the gene in the eye, restoring vision to treated children and adults with one form of LCA and “enabling the entire field of gene therapy for human disease,” the foundation said.

These teams are comprised of U.S. scientists Jean Bennett and Albert Maguire; Samuel Jacobson and William Hauswirth; and Britons Robin Ali and James Bainbridge.

Also Read: India Aims Towards Highest Level Of Health

Their gene augmentation therapy involved the delivery of healthy genes using engineered harmless viruses, described by the foundation as “an elegant solution.”

The foundation, which focuses on neuroscience and oncology research at its Lisbon base, was set up at the bequest of Portugal’s late industrialist Antonio Champalimaud who died in 2004. The first vision prize was awarded in 2006. (VOA)